Clinical Trial Update: Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of acyclovir for herpes simplex virus affecting skin, eye, and mouth has completed; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex

Drugs mentioned

• ACYCLOVIR (Acyclovir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Herpes Simplex | Phase 3 | Status: COMPLETED | Results posted: 2010-04-09